As organizations across industries race to integrate advanced AI capabilities into their mission-critical systems, the stakes for software security have ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I address how you can discover hidden best ...
With the right governance, organizations can scale generative AI securely and build lasting trust.
The International Medical Device Regulators Forum (IMDRF) has released a draft technical document to create a harmonized set ...
As adoption accelerates, AI is changing the speed, scale, and sophistication of cyber defense and offense, placing ...
Georgia Tech researchers have created a new AI model for decision-focused learning (DFL), called Diffusion-DFL. Recent tests ...
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...
Generative AI can augment chemometrics by automating curation, connecting analytical outputs to textual knowledge, and ...
As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results